(Q36360818)
Statements
TT232, a novel signal transduction inhibitory compound in the therapy of cancer and inflammatory diseases (English)
Orsolya Szokolóczi
Richárd Schwab
István Peták
Akos Pap
Alex N Eberle
Tamás Szüts
1 January 2005
1 reference